Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New Locations section added with Ohio and Wisconsin sites, replacing the previous separate Ohio Locations and Wisconsin Locations sections.
    Difference
    0.3%
    Check dated 2025-12-24T13:58:27.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 to the revisions section. Deleted Revision: v3.2.0 from the revisions history.
    Difference
    0.0%
    Check dated 2025-11-25T13:35:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Removed an administrative notice about government funding and operating status. The content now focuses on the study details and locations.
    Difference
    0.3%
    Check dated 2025-11-18T07:23:23.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    New screenshot indicates minor text edits and formatting adjustments with no changes to the core study details, interventions, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:58:58.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T07:55:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a new reference for Nivolumab plus ipilimumab in advanced melanoma and updated the page version to v3.1.0; removed a closely related Genetics Information Center entry and older version, effectively replacing the reference with an updated citation. Overall, bibliographic updates with minor versioning, no other substantive content changes.
    Difference
    0.5%
    Check dated 2025-09-29T04:31:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.